ethyl 5-cyclohexyl-2-(1,3-thiazol-2-yl)-1H-imidazole-4-carboxylate | 910475-28-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: ethyl 5-cyclohexyl-2-(1,3-thiazol-2-yl)-1H-imidazole-4-carboxylate
• CAS: 910475-28-4
• 化学式: C₁₅H₁₉N₃O₂S
• 分子量: 305.401
• InChiKey: ZISMIHNWFFUEMP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  21
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  96.1
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  ethyl 5-cyclohexyl-2-(1,3-thiazol-2-yl)-1H-imidazole-4-carboxylate 、 碘甲烷 在 sodium hydride 作用下， 以 四氢呋喃 为溶剂， 反应 13.0h， 生成 Ethyl 5-cyclohexyl-1-methyl-2-(1,3-thiazol-2-yl)imidazole-4-carboxylate
  参考文献：
  名称：

  THIAZOLE NON-NUCLEOSIDE COMPOUNDS, THEIR PREPARATION, PHARMACEUTICAL COMPOSITION AND THEIR USE AS ANTIVIRAL AGENTS

  摘要：

  公开号：

  EP2030974B1

文献信息

• Bisheterocycle Tandem Compounds Useful as Antiviral Agents, the Uses Thereof and the Compositions Comprising Such Compounds
  申请人：Nan Fajun

  公开号：US20080306121A1

  公开（公告）日：2008-12-11

  The present invention provides small molecule compounds of bisheterocycle in tandem having the structural formula of P1-P2, and the use thereof as well as a composition containing the compounds, each of P1 and P2 is an unsaturated 5-member heterocyclic ring having one or two heteroatoms. This compound may effectively inhibit the replication of influenza virus, the DNA replication of hepatitis B virus (HBV), and the formation of HBsAg and HBeAg. These compounds can be used for the preparation of a medicament for viral diseases, and may overcome the limitations of the known nucleosides drugs, including cytotoxicity, the requirement of other drugs having different structures for against the drug-resistant virus variants induced by long-term therapy. The structure of the compounds according to the invention is relatively simple and easy to be prepared.

  本发明提供了具有P1-P2结构式的串联双杂环小分子化合物，以及其用途和含有这些化合物的组合物，其中P1和P2分别是具有一个或两个杂原子的不饱和5元杂环。该化合物可以有效抑制流感病毒的复制、乙型肝炎病毒（HBV）的DNA复制以及HBsAg和HBeAg的形成。这些化合物可用于制备用于病毒性疾病的药物，并且可能克服已知核苷类药物的局限性，包括细胞毒性、长期治疗引起的对抗药物耐药病毒变异所需其他结构不同的药物。根据本发明的化合物结构相对简单且易于制备。
• HETEROCYCLIC NON-NUCLEOSIDE COMPOUNDS, THEIR PEPARATION, PHARMACEUTICAL COMPOSITION AND THEIR USE AS ANTIVIRAL AGENTS
  申请人：Shanghai Institute of Materia Medica, Chinese Academy of Sciences

  公开号：EP2030974A1

  公开（公告）日：2009-03-04

  The invention relates a kind of antiviral agents, more concretely, relates to a kind of heterocyclic non-nucleoside compounds with the following structures, their preparation and pharmaceutical compositions including the compounds. The said compounds can be used as antiviral agents and as medicaments for treating diseases such as hepatitis B, influenza, herpes, HIV and so on.

  本发明涉及一种抗病毒剂，更具体地，涉及一种具有以下结构的杂环非核苷类化合物，以及它们的制备和包括这些化合物的药物组合物。所述化合物可用作抗病毒剂，以及用于治疗乙型肝炎、流感、疱疹、人类免疫缺陷病毒等疾病的药物。
• 2-2'-Bis-thiazole derivatives as antiviral agents
  申请人：Shanghai Institute Of Materia Medica Chinese Academy of Sciences

  公开号：EP2218720A1

  公开（公告）日：2010-08-18

  The present invention provides small molecule compounds of bisheterocycle in tandem having the structural formula of P1-P2, and the use thereof as well as a composition containing the compounds, each of P1 and P2 is an unsaturated 5-member heterocyclic ring having one or two heteroatoms. This compound may effectively inhibit the replication of influenza virus, the DNA replication of hepatitis B virus (HBV), and the formation of HBsAg and HBeAg. These compounds can be used for the preparation of a medicament for viral diseases, and may overcome the limitations of the known nucleosides drugs, including cytotoxicity, the requirement of other drugs having different structures for against the drug-resistant virus variants induced by long-term therapy. The structure of the compounds according to the invention is relatively simple and easy to be prepared.

  本发明提供了结构式为P1-P2的串联双杂环小分子化合物及其用途以及含有该化合物的组合物，其中P1和P2各自为具有一个或两个杂原子的不饱和五元杂环。这种化合物可有效抑制流感病毒的复制、乙型肝炎病毒（HBV）DNA 的复制以及 HBsAg 和 HBeAg 的形成。这些化合物可用于制备治疗病毒性疾病的药物，并可克服已知核苷类药物的局限性，包括细胞毒性、需要使用其他不同结构的药物来对付长期治疗诱发的耐药病毒变种。本发明化合物的结构相对简单，易于制备。
• Heterocyclic Non-Nucleoside Compounds, Their Preparation, Pharmaceutical Composition And Their Use As Antiviral Agents
  申请人：Nan Fajun

  公开号：US20100056569A1

  公开（公告）日：2010-03-04

  The invention relates a kind of antiviral agents, more concretely, relates to a kind of heterocyclic non-nucleoside compounds with the following structures, their preparation and pharmaceutical compositions including the compounds. The said compounds can be used as antiviral agents and as medicaments for treating diseases such as hepatitis B, influenza, herpes, HIV and so on.
• US7741348B2
  申请人：——

  公开号：US7741348B2

  公开（公告）日：2010-06-22